Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 3, 2005, Pages 1502-1510

  Page, Stephanie T ^c   Amory, John K ^c   Bowman, F DuBois ^b   Anawalt, Bradley D ^c   Matsumoto, Alvin M ^c   Bremner, William J ^c   Tenover, J Lisa ^a,d  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ANDROGEN; ANDROSTANOLONE; CHOLESTEROL; FINASTERIDE; HEPTANOIC ACID DERIVATIVE; HIGH DENSITY LIPOPROTEIN; HORMONE; INSULIN; LEPTIN; LOW DENSITY LIPOPROTEIN; PROSTATE SPECIFIC ANTIGEN; TESTOSTERONE; ENZYME INHIBITOR; LIPID; SIGNAL PEPTIDE;

AGED; ARTICLE; BODY COMPOSITION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FUNCTIONAL ASSESSMENT; GRIP STRENGTH; HORMONAL THERAPY; HORMONE SUBSTITUTION; HUMAN; HYPOGONADISM; LEAN BODY WEIGHT; MALE; MEASUREMENT; ORGAN SIZE; OUTCOMES RESEARCH; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; PROSTATE; RANDOMIZED CONTROLLED TRIAL; SCANNING ELECTRON MICROSCOPY; TESTOSTERONE BLOOD LEVEL; AGING; BLOOD; BODY MASS; DOUBLE BLIND PROCEDURE; DRUG COMBINATION; DRUG EFFECT; HAND GRIP; MOTOR ACTIVITY; PATHOPHYSIOLOGY;

ADIPONECTIN; AGED; AGED, 80 AND OVER; AGING; ANDROGENS; BODY COMPOSITION; BODY MASS INDEX; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; ENZYME INHIBITORS; FINASTERIDE; HAND STRENGTH; HUMANS; HYPOGONADISM; INSULIN; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LEPTIN; LIPIDS; MALE; MOTOR ACTIVITY; TESTOSTERONE;

EID: 15944404290     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-1933     Document Type: Article

References (47)

1. Larsson L, Grimby G, Karlsson J 1979 Muscle strength and speed of movement in relation to age and muscle morphology. J Appl Physiol 46:451-456
2. Danneskiold-Samsoe B, Kofod V, Munter J, Grimby G, Schnohr P, Jensen G 1984 Muscle strength and functional capacity in 78-81-year-old men and women. Eur J Appl Physiol Occup Physiol 52:310-314
3. Frontera WR, Hughes VA, Lutz KJ, Evans WJ 1991 A cross-sectional study of muscle strength and mass in 45- to 78-yr-old men and women. J Appl Physiol 71:644-650
4. Forbes GB, Reina JC 1970 Adult lean body mass declines with age: some longitudinal observations. Metabolism 19:653-663
5. Baumgartner RN, Stauber PM, McHugh D, Koehler KM, Carry PJ 1995 Cross-sectional age differences in body composition in persons 60+ years of age. J Gerontol A Biol Sci Med Sci 50:M307-M316
6. Steen B 1988 Body composition and aging. Nutr Rev 46:45-51
7. Tenover JS 1998 Androgen replacement therapy to reverse and/or prevent age-associated sarcopenia in men. Baillieres Clin Endocrinol Metab 12:419-425
8. Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR 2001 Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 86:724-731
9. Feldman HA, Longcope C, Derby CA, Johannes CB, Araujo AB, Coviello AD, Bremner WJ, McKinlay JB 2002 Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab 87:589-598
10. Snyder PJ, Peachey H, Hannoush P, Berlin JA, Loh L, Lenrow DA, Holmes JH, Dlewati A, Santanna J, Rosen CJ, Strom BL 1999 Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age. J Clin Endocrinol Metab 84:2647-2653
11. Katznelson L, Finkelstein JS, Schoenfeld DA, Rosenthal DI, Andersen EJ, Klibanski A 1996 Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. J Clin Endocrinol Metab 81:4358-4365
12. Tenover JS 1992 Effects of testosterone supplementation in the aging male. J Clin Endocrinol Metab 75:1092-1098
13. Amory JK, Watts NB, Easley KA, Sutton PR, Anawalt BD, Matsumoto AM, Bremner WJ, Tenover JL 2004 Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone. J Clin Endocrinol Metab 89:503-510
14. Sih R, Morley JE, Kaiser FE, Perry 3rd HM, Patrick P, Ross C 1997 Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial. J Clin Endocrinol Metab 82:1661-1667
15. Ferrando AA, Sheffield-Moore M, Yeckel CW, Gilkison C, Jiang J, Achacosa A, Lieberman SA, Tipton K, Wolfe RR, Urban RJ 2002 Testosterone administration to older men improves muscle function: molecular and physiological mechanisms. Am J Physiol Endocrinol Metab 282:E601-E607
16. Whitsel EA, Boyko EJ, Matsumoto AM, Anawalt BD, Siscovick DS 2001 Intramuscular testosterone esters and plasma lipids in hypogonadal men: a meta-analysis. Am J Med 111:261-269
17. Gruenewald DA, Matsumoto AM 2003 Testosterone supplementation therapy for older men: potential benefits and risks. J Am Geriatr Soc 51:101-115; discussion 115
18. Steers WD 2001 5α-Reductase activity in the prostate. Urology 58:17-24; discussion 24
19. Roehrborn CG, Lee M, Meehan A, Waldstreicher J 2003 Effects of finasteride on serum testosterone and body mass index in men with benign prostatic hyperplasia. Urology 62:894-899
20. Reuben DB, Siu AL 1990 An objective measure of physical function of elderly outpatients. The Physical Performance Test. J Am Geriatr Soc 38:1105-1112
21. WHO 1989 Measuring obesity. Classification and description of anthropometric data. EUR/HFA 15. Copenhagen: World Health Organization
22. Kenny AM, Prestwood KM, Gruman CA, Marcello KM, Raisz LG 2001 Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels. J Gerontol A Biol Sci Med Sci 56:M266-M272
23. Brill KT, Weltman AL, Gentili A, Patrie JT, Fryburg DA, Hanks JB, Urban RJ, Veldhuis JD 2002 Single and combined effects of growth hormone and testosterone administration on measures of body composition, physical performance, mood, sexual function, bone turnover, and muscle gene expression in healthy older men. J Clin Endocrinol Metab 87:5649-5657
24. Blackman MR, Sorkin JD, Munzer T, Bellantoni MF, Busby-Whitehead J, Stevens TE, Jayme J, O'Connor KG, Christmas C, Tobin JD, Stewart KJ, Cottrell E, St Clair C, Pabst KM, Harman SM 2002 Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial. JAMA 288:2282-2292
25. Szuk P, Claustrat B, Marchand F, Delmas PD 2003 Increased risk of falls and increased bone resorption in elderly men with partial androgen deficiency: the MINOS study. J Clin Endocrinol Metab 88:5240-5247
26. Jackson JA, Riggs MW, Spiekerman AM 1992 Testosterone deficiency as a risk factor for hip fractures in men: a case-control study. Am J Med Sci 304:4-8
27. Snyder PJ, Peachey H, Hannoush P, Berlin JA, Loh L, Holmes JH, Dlewati A, Staley J, Santanna J, Kapoor SC, Attie MF, Haddad Jr JG, Strom BL 1999 Effect of testosterone treatment on bone mineral density in men over 65 years of age. J Clin Endocrinol Metab 84:1966-1972
28. Wang C, Swerdloff RS, Iranmanesh A, Dobs A, Snyder PJ, Cunningham G, Matsumoto AM, Weber T, Berman N 2001 Effects of transdermal testosterone gel on bone turnover markers and bone mineral density in hypogonadal men. Clin Endocrinol (Oxf) 54:739-750
29. Reuben DB, Siu AL, Kimpau S 1992 The predictive validity of self-report and performance-based measures of function and health. J Gerontol 47:M106-M110
30. Bhasin S 2003 Testosterone supplementation for aging-associated sarcopenia. J Gerontol A Biol Sci Med Sci 58:1002-1008
31. Storer TW, Magliano L, Woodhouse L, Lee ML, Dzekov C, Dzekov J, Casaburi R, Bhasin S 2003 Testosterone dose-dependently increases maximal voluntary strength and leg power, but does not affect fatigability or specific tension. J Clin Endocrinol Metab 88:1478-1485
32. Sinha-Hikim I, Artaza J, Woodhouse L, Gonzalez-Cadavid N, Singh AB, Lee MI, Storer TW, Casaburi R, Shen R, Bhasin S 2002 Testosterone-induced increase in muscle size in healthy young men is associated with muscle fiber hypertrophy. Am J Physiol Endocrinol Metab 283:E154-E164
33. Bhasin S, Woodhouse L, Casaburi R, Singh AB, Bhasin D, Berman N, Chen X, Yarasheski KE, Magliano L, Dzekov C, Dzekov J, Bross R, Phillips J, Sinha-Hikim I, Shen R, Storer TW 2001 Testosterone dose-response relationships in healthy young men. Am J Physiol Endocrinol Metab 281:E1172-E1181
34. Holmang S, Marin P, Lindstedt G, Hedelin H 1993 Effect of long-term oral testosterone undecanoate treatment on prostate volume and serum prostatespecific antigen concentration in eugonadal middle-aged men. Prostate 23:99-106
35. Herbst KL, Anawalt BD, Amory JK, Matsumoto AM, Bremner WJ 2003 The male contraceptive regimen of testosterone and levonorgestrel significantly increases lean mass in healthy young men in 4 weeks, but attenuates a decrease in fat mass induced by testosterone alone. J Clin Endocrinol Metab 88:1167-1173
36. Marin P, Krotkiewski M, Bjorntorp P 1992 Androgen treatment of middle-aged, obese men: effects on metabolism, muscle and adipose tissues. Eur J Med 1:329-336
37. Marin P, Holmang S, Jonsson L, Sjostrom L, Kvist H, Holm G, Lindstedt G, Bjorntorp P 1992 The effects of testosterone treatment on body composition and metabolism in middle-aged obese men. Int J Obes Relat Metab Disord 16:991-997
38. Woodhouse LJ, Gupta N, Bhasin M, Singh AB, Ross R, Phillips J, Bhasin S 2004 Dose-dependent effects of testosterone on regional adipose tissue distribution in healthy young men. J Clin Endocrinol Metab 89:718-726
39. Liu PY, Wishart SM, Celermajer DS, Jimenez M, Pierro ID, Conway AJ, Handelsman DJ 2003 Do reproductive hormones modify insulin, sensitivity and metabolism in older men? A randomized, placebo-controlled clinical trial of recombinant human chorionic gonadotropin. Eur J Endocrinol 148:55-66
40. Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, Retzlaff BM, Knopp RH, Brunzell JD, Kahn SE 2003 Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 46:459-469
41. Nishizawa H, Shimomura I, Kishida K, Maeda N, Kuriyama H, Nagaretani H, Matsuda M, Kondo H, Furuyama N, Kihara S, Nakamura T, Tochino Y, Funahashi T, Matsuzawa Y 2002 Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes 51:2734-2741
42. Esposito K, Pontillo A, Di Palo C, Giugliano G, Masella M, Marfella R, Giugliano D 2003 Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA 289:1799-1804
43. Yang WS, Lee WJ, Funahashi T, Tanaka S, Matsuzawa Y, Chao CL, Chen CL, Tai TY, Chuang LM 2001 Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 86:3815-3819
44. Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB 2004 Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 291:1730-1737
45. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T, Matsuzawa Y 2000 Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20:1595-1599
46. Page ST, Herbst KL, Amory JK, Coviello AD, Anawalt BD, Matsumoto AM, Bremner WJ 2005 Testosterone suppresses adiponectin levels in men. J Androl 26:85-92
47. Lanfranco F, Zitzmann M, Simoni M, Nieschlag E 2004 Serum adiponectin levels in hypogonadal males: influence of testosterone replacement therapy. Clin Endocrinol (Oxf) 60:500-507